Auxilium to Host Telcon and Webcast on Wednesday, February THREE at 8:30 a.m. Eastern Time MALVERN, PA, Feb 2 –(HSMN NewsFeed) - Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL ), a specialty biopharmaceutical company, today announced that it has rece…
Biopharmaceuticals, FDA
Auxilium Pharmaceuticals, XIAFLEX, Dupuytren’s contracture

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren’s Contracture”
Leave a Comment